Vistogard Approved for Chemotherapy Overdose

FRIDAY, Dec. 11, 2015 — Vistogard (uridine triacetate) has been approved by the U.S. Food and Drug Administration to treat an overdose of chemotherapy drugs commonly used to treat cancers of the breast and gastrointestinal tract.
The drugs are…
Source: Topamax